NEW | EMA update on Q&As for biological medicinal products

October 3, 2023

EMA has issued an update on the Questions and Answers for biological human medicinal products, providing agreed positions by the Biologics Working Party on issues that can be subject to different interpretation or require clarification, typically arising from discussions or correspondence during assessment procedures of biological human medicinal products.

The topics covered include, among others:

  • Reprocessing (3.2.S.2.2, 3.2.P.3.3)
  • Raw materials and media components (3.2.S.2.3)
  • Method identification numbers (3.2.S.4.1, 3.2.P.5.1)
  • Process validation, removal of process related impurities, process related impurities testing (3.2.S.2.5, 3.2.P.3.5)
  • Host cell proteins testing, drug substance specification (3.2.S.3.2, 3.2.S.4.1, 3.2.S.4.5)
  • Biosimilar medicinal products: characterization, side-by-side comparison, specification, biosimilarity, analytical comparability (3.2.S, 3.2.S.3.1, 3.2.S.4.1, 3.2.P.5.1, 3.2.R)


You can have a look at the complete document here: Q&As for biological medicinal products EMA

At Asphalion, we are seasoned experts in CMC and we can support you in all your projects.

Contact us at:

Or schedule a free 30-minute meeting here: SCHEDULE A MEETING

Search News & Events

  • Filter by category


Related news and events


A lot of things have happened at Asphalion during these past three months, and we have summarized the highlights in a two minutes video. You

EVENT | CPHI congress

Barcelona, 24-26 October 🔜 Visit us at stand 2R60!! Meet ASPHALION experts in Barcelona and discover all the solutions we can provide you with at

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting